136 related articles for article (PubMed ID: 17459056)
1. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.
Kawasaki T; Yokoi S; Tsuda H; Izumi H; Kozaki K; Aida S; Ozeki Y; Yoshizawa Y; Imoto I; Inazawa J
Cancer Sci; 2007 Jul; 98(7):1070-7. PubMed ID: 17459056
[TBL] [Abstract][Full Text] [Related]
2. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
[TBL] [Abstract][Full Text] [Related]
3. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
[TBL] [Abstract][Full Text] [Related]
4. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
[TBL] [Abstract][Full Text] [Related]
5. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
6. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
7. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.
Mei YP; Liao JP; Shen J; Yu L; Liu BL; Liu L; Li RY; Ji L; Dorsey SG; Jiang ZR; Katz RL; Wang JY; Jiang F
Oncogene; 2012 May; 31(22):2794-804. PubMed ID: 21986946
[TBL] [Abstract][Full Text] [Related]
8. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
[TBL] [Abstract][Full Text] [Related]
9. Mandatory chromosomal segment balance in aneuploid tumor cells.
Kost-Alimova M; Darai-Ramqvist E; Yau WL; Sandlund A; Fedorova L; Yang Y; Kholodnyuk I; Cheng Y; Li Lung M; Stanbridge E; Klein G; Imreh S
BMC Cancer; 2007 Jan; 7():21. PubMed ID: 17257397
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
11. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.
Gallegos Ruiz MI; Floor K; Roepman P; Rodriguez JA; Meijer GA; Mooi WJ; Jassem E; Niklinski J; Muley T; van Zandwijk N; Smit EF; Beebe K; Neckers L; Ylstra B; Giaccone G
PLoS One; 2008 Mar; 3(3):e0001722. PubMed ID: 18320023
[TBL] [Abstract][Full Text] [Related]
12. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
[TBL] [Abstract][Full Text] [Related]
13. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
[TBL] [Abstract][Full Text] [Related]
14. Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer.
Castillo SD; Angulo B; Suarez-Gauthier A; Melchor L; Medina PP; Sanchez-Verde L; Torres-Lanzas J; Pita G; Benitez J; Sanchez-Cespedes M
J Pathol; 2010 Sep; 222(1):89-98. PubMed ID: 20556744
[TBL] [Abstract][Full Text] [Related]
15. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line.
Taguchi T; Cheng GZ; Bell DW; Balsara B; Liu Z; Siegfried JM; Testa JR
Genes Chromosomes Cancer; 1997 Oct; 20(2):208-12. PubMed ID: 9331573
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon.
Eijdems EW; De Haas M; Coco-Martin JM; Ottenheim CP; Zaman GJ; Dauwerse HG; Breuning MH; Twentyman PR; Borst P; Baas F
Int J Cancer; 1995 Mar; 60(5):676-84. PubMed ID: 7860142
[TBL] [Abstract][Full Text] [Related]
17. Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC.
Zito Marino F; Botti G; Aquino G; Ferrero S; Gaudioso G; Palleschi A; Rocco D; Salvi R; Micheli MC; Micheli P; Morabito A; Rocco G; Giordano A; De Cecio R; Franco R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664698
[No Abstract] [Full Text] [Related]
18. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
19. MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.
Kubo T; Yamamoto H; Lockwood WW; Valencia I; Soh J; Peyton M; Jida M; Otani H; Fujii T; Ouchida M; Takigawa N; Kiura K; Shimizu K; Date H; Minna JD; Varella-Garcia M; Lam WL; Gazdar AF; Toyooka S
Int J Cancer; 2009 Apr; 124(8):1778-84. PubMed ID: 19117057
[TBL] [Abstract][Full Text] [Related]
20. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
Kim YH; Kwei KA; Girard L; Salari K; Kao J; Pacyna-Gengelbach M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
Oncogene; 2010 Mar; 29(10):1421-30. PubMed ID: 19966867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
